Amar Upadhyaya Kishan

Title(s)Department Vice Chair, Radiation Oncology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Professor-in-residence, Radiation Oncology

    Title(s)Professor-in-residence, Urology


    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis. Eur Urol. 2024 Apr 02. Roy S, Fervaha G, Spratt DE, Sun Y, Kishan AU, Loblaw A, Malone S, Ong M, Saad F, Wallis CJD, Morgan SC. PMID: 38570246.
      View in: PubMed   Mentions:    Fields:    
    2. Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study. Eur Urol. 2024 Apr; 85(4):398-400. Roy S, Saad F, Malone S, Agarwal N, Mohamad O, Morgan SC, Malone J, Swami U, Jia AY, Gebrael G, Mendiratta P, Brown JR, Rao SK, Sun Y, Wallis CJD, Chi KN, Chowdhury S, Kishan AU, Spratt DE. PMID: 38485300.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Intra-fractional geometric and dose/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy. Phys Imaging Radiat Oncol. 2024 Apr; 30:100573. Gao Y, Yoon S, Ma TM, Yang Y, Sheng K, Low DA, Ballas L, Steinberg ML, Kishan AU, Cao M. PMID: 38585371; PMCID: PMC10997948.
      View in: PubMed   Mentions:
    4. Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Front Oncol. 2024; 14:1381134. Repka MC, Sholklapper T, Zwart AL, Danner M, Ayoob M, Yung T, Lei S, Collins BT, Kumar D, Suy S, Hankins RA, Kishan AU, Collins SP. PMID: 38585005; PMCID: PMC10995255.
      View in: PubMed   Mentions:
    5. Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer. World J Urol. 2024 Mar 16; 42(1):165. Nikitas J, Kishan A, Chang A, Duriseti S, Nichols NG, Reiter R, Rettig M, Brisbane W, Steinberg ML, Valle L. PMID: 38492111.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial. Eur Urol. 2024 Mar 16. Nikitas J, Rettig M, Shen J, Reiter R, Lee A, Steinberg ML, Valle LF, Sachdeva A, Romero T, Calais J, Czernin J, Nickols NG, Kishan AU. PMID: 38494380.
      View in: PubMed   Mentions:    Fields:    
    7. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. Eur Urol. 2024 Mar 14. Nickols NG, Tsai S, Kane N, Tran S, Ghayouri L, Diaz-Perez S, Thein M, Anderson-Berman N, Eason J, Kishan AU, Steinberg ML, Reiter RE, Lee SP, Gin GE, Kwon R, Chang MG, Chao HH, Solanki AA, Sexton R, Lewis M, Lorentz W, Cheung MK, Gage DL, Duriseti S, Valle L, Berenji G, Aronson WJ, Garraway IP, Rettig MB. PMID: 38490853.
      View in: PubMed   Mentions:    Fields:    
    8. The Potential Contribution of Radiopharmaceutical Therapies in Managing Oligometastatic Disease. J Nucl Med. 2024 Feb 15. Kishan AU, Siva S, Hofman MS, Nagarajah J, Kiess AP, Tran P, Calais J. PMID: 38360048.
      View in: PubMed   Mentions:    Fields:    
    9. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774). Eur Urol. 2024 Jan 29. Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J. PMID: 38290964.
      View in: PubMed   Mentions:    Fields:    
    10. Impact of PSMA PET on Prostate Cancer Management. Curr Treat Options Oncol. 2024 Feb; 25(2):191-205. Weiner AB, Agrawal R, Valle LF, Sonni I, Kishan AU, Rettig MB, Raman SS, Calais J, Boutros PC, Reiter RE. PMID: 38270802.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning. J Magn Reson Imaging. 2024 Jan 24. McGee KP, Cao M, Das IJ, Yu V, Witte RJ, Kishan AU, Valle LF, Wiesinger F, De-Colle C, Cao Y, Breen WG, Traughber BJ. PMID: 38265188.
      View in: PubMed   Mentions:    Fields:    
    12. Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer. World J Urol. 2024 Jan 20; 42(1):41. Lilleby W, Kishan A, Geinitz H. PMID: 38244053; PMCID: PMC10799812.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape. Cancers (Basel). 2024 Jan 08; 16(2). Ocanto A, Torres L, Montijano M, Rincón D, Fernández C, Sevilla B, Gonsalves D, Teja M, Guijarro M, Glaría L, Hernánz R, Zafra-Martin J, Sanmamed N, Kishan A, Alongi F, Moghanaki D, Nagar H, Couñago F. PMID: 38254760; PMCID: PMC10813892.
      View in: PubMed   Mentions:
    14. MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing. Semin Radiat Oncol. 2024 01; 34(1):45-55. Westley RL, Valle LF, Tree AC, Kishan AU. PMID: 38105093.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial. Int J Radiat Oncol Biol Phys. 2023 Dec 30. Neylon J, Ma TM, Savjani R, Low DA, Steinberg ML, Lamb JM, Nickols NG, Kishan AU, Cao M. PMID: 38160916.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    16. Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. Int J Radiat Oncol Biol Phys. 2023 Dec 25. Nikitas J, Ong WL, Carrier N, Romero T, Millar J, Steinberg ML, Rettig MB, Boutros PC, Reiter R, Nickols NG, Valle L, McGuire SE, Spratt DE, Souhami L, Roy S, Martin JM, Joseph D, Nabid A, Kishan AU. PMID: 38151191.
      View in: PubMed   Mentions:    Fields:    
    17. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis. Med Phys. 2024 Jan; 51(1):612-621. Pham J, Neilsen BK, Liu H, Cao M, Yang Y, Sheng K, Ma TM, Kishan AU, Ruan D. PMID: 38055353.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    18. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer. JAMA Netw Open. 2023 Dec 01; 6(12):e2345906. Ma TM, Agarwal N, Mahal B, Barragan-Carrillo R, Spratt D, Rettig MB, Valle LF, Steinberg ML, Garraway I, Vapiwala N, Xiang M, Kishan AU. PMID: 38039002; PMCID: PMC10692845.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. Radiat Oncol. 2023 Nov 11; 18(1):188. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM. PMID: 37950310; PMCID: PMC10638743.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2023 Nov 03. Roy S, Malone S, Sun Y, Zaorsky NG, Spratt DE, Morgan SC, Dess RT, Wallis CJD, Kishan AU, Citrin DE, Saad F. PMID: 37924987.
      View in: PubMed   Mentions:    Fields:    
    21. Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):146-153. Shimomura A, Wu T, Rusu I, Kishan AU, Tree AC, Solanki AA, Liauw SL. PMID: 37875222.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118(4):986-997. Neilsen BK, Ma TM, Akingbemi WO, Neylon J, Casado MC, Sharma S, Sheng K, Ruan D, Low DA, Yang Y, Valle LF, Steinberg ML, Lamb JM, Cao M, Kishan AU. PMID: 37871887.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    23. Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate Cancer. Eur Urol. 2024 01; 85(1):47-48. Kishan AU, Valle LF, Marks LS. PMID: 37805372.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trial. World J Urol. 2023 Dec; 41(12):3905-3911. Roy S, Kishan AU, Morgan SC, Martinka L, Spratt DE, Sun Y, Malone J, Grimes S, Citrin DE, Malone S. PMID: 37792009.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    25. Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR. Int J Radiat Oncol Biol Phys. 2023 Oct 04. Ong WL, Nikitas J, Joseph D, Steigler A, Millar J, Valle L, Steinberg ML, Ma TM, Reiter RE, Rettig MB, Nickols NG, Chang A, Zaorsky NG, Spratt DE, Romero T, Kishan AU. PMID: 37802226.
      View in: PubMed   Mentions: 1     Fields:    
    26. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT). BMC Cancer. 2023 Sep 30; 23(1):923. Wolfe S, Diven MA, Marciscano AE, Zhou XK, Kishan AU, Steinberg ML, Miccio JA, Camilleri P, Nagar H. PMID: 37777738; PMCID: PMC10544147.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    27. Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis. Clin Oncol (R Coll Radiol). 2023 12; 35(12):e676-e688. Subiela JD, Gomis Sellés E, Maldonado A, Lopez Campos F, Aumatell Ovide J, Ajuria Illarramendi O, González-Padilla DA, Gajate P, Ortega Polledo LE, Alonso Y Gregorio S, Guerrero-Ramos F, Gómez Dos Santos V, Rodríguez-Patrón R, Calais J, Kishan AU, Burgos Revilla FJ, Couñago F. PMID: 37802722.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation. Cancers (Basel). 2023 Sep 21; 15(18). Benitez CM, Steinberg ML, Cao M, Qi XS, Lamb JM, Kishan AU, Valle LF. PMID: 37760626; PMCID: PMC10526919.
      View in: PubMed   Mentions: 1  
    29. Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study. Eur J Cancer. 2024 Mar; 199:113348. Roy S, Saad F, Wallis CJD, Sun Y, Spratt DE, Akilla R, Kishan AU, Malone S, Morgan SC. PMID: 38262848.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):e117-e131. Ma TM, Ladbury C, Tran M, Keiper TD, Andraos T, Gogineni E, Mohideen N, Siva S, Loblaw A, Tree AC, Cheung P, Kresl J, Collins S, Cao M, Kishan AU. PMID: 37661040.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer. Cancers (Basel). 2023 Sep 02; 15(17). Roy S, Sun Y, Wallis CJD, Kishan AU, Morgan SC, Spratt DE, Malone S, Saad F. PMID: 37686668; PMCID: PMC10486494.
      View in: PubMed   Mentions:
    32. Selecting the optimal radiation modality in prostate cancer. Clin Adv Hematol Oncol. 2023 Sep; 21(9):494-501. Valle LF, Kishan AU, Franco A, Ma TM, Nikitas J, Farrell M, Chang AJ, Nickols NG, Steinberg ML. PMID: 37647496.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection. Med Phys. 2023 Oct; 50(10):6525-6534. Frank CH, Ramesh P, Lyu Q, Ruan D, Park SJ, Chang AJ, Venkat PS, Kishan AU, Sheng K. PMID: 37650773; PMCID: PMC10635680.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Human factors in the clinical implementation of deep learning-based automated contouring of pelvic organs at risk for MRI-guided radiotherapy. Med Phys. 2023 Oct; 50(10):5969-5977. Abdulkadir Y, Luximon D, Morris E, Chow P, Kishan AU, Mikaeilian A, Lamb JM. PMID: 37646527.
      View in: PubMed   Mentions:    Fields:    
    35. Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. J Clin Oncol. 2023 Nov 10; 41(32):5005-5014. Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. PMID: 37639648; PMCID: PMC10642893.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Performance Analysis of a Radiation Oncology Educational Podcast. J Am Coll Radiol. 2024 Jan; 21(1):186-191. Wu TC, No HJ, Rahimy E, Kishan AU, Steinberg ML, Raldow AC, Beadle BM. PMID: 37516159.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional Trial. Eur Urol. 2023 12; 84(6):600-601. Jia AY, Kishan AU, Spratt DE. PMID: 37438199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature. Eur Urol Oncol. 2024 Feb; 7(1):27-43. Sood A, Kishan AU, Evans CP, Feng FY, Morgan TM, Murphy DG, Padhani AR, Pinto P, Van der Poel HG, Tilki D, Briganti A, Abdollah F. PMID: 37423774.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Use of focal radiotherapy boost for prostate cancer and perceived barriers toward its implementation: a survey. medRxiv. 2023 Jun 08. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM. PMID: 37333345; PMCID: PMC10274968.
      View in: PubMed   Mentions:
    40. Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy. Eur Urol. 2023 09; 84(3):257-259. Jiang T, Valle LF, Kishan AU. PMID: 37246070.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial. Int J Radiat Oncol Biol Phys. 2023 10 01; 117(2):348-354. Ma TM, Wong DJ, Chai-Ho W, Mendelsohn A, St John M, Abemayor E, Chhetri D, Sajed D, Dang A, Chu FI, Xiang M, Savjanji R, Weidhaas J, Steinberg ML, Cao M, Kishan AU, Chin RK. PMID: 37141981.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    42. Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer. Prostate. 2023 07; 83(10):912-921. Roy S, Wallis CJD, Morgan SC, Kishan AU, Le ATT, Malone J, Sun Y, Spratt DE, Saad F, Malone S. PMID: 37071764.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    43. A novel prostate cancer subtyping classifier based on luminal and basal phenotypes. Cancer. 2023 07 15; 129(14):2169-2178. Weiner AB, Liu Y, Hakansson A, Zhao X, Proudfoot JA, Ho J, Zhang JH, Li EV, Karnes RJ, Den RB, Kishan AU, Reiter RE, Hamid AA, Ross AE, Tran PT, Davicioni E, Spratt DE, Attard G, Lotan TL, Lee Kiang Chua M, Sweeney CJ, Schaeffer EM. PMID: 37060201.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. A polygenic two-hit hypothesis for prostate cancer. J Natl Cancer Inst. 2023 04 11; 115(4):468-472. Houlahan KE, Livingstone J, Fox NS, Kurganovs N, Zhu H, Sietsma Penington J, Jung CH, Yamaguchi TN, Heisler LE, Jovelin R, Costello AJ, Pope BJ, Kishan AU, Corcoran NM, Bristow RG, Waszak SM, Weischenfeldt J, He HH, Hung RJ, Hovens CM, Boutros PC. PMID: 36610996; PMCID: PMC10086625.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Advances in MRI-Guided Radiation Therapy. Surg Oncol Clin N Am. 2023 07; 32(3):599-615. Chuong MD, Palm RF, Tjong MC, Hyer DE, Kishan AU. PMID: 37182995.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial. JAMA Oncol. 2023 04 01; 9(4):511-518. Mariados NF, Orio PF, Schiffman Z, Van TJ, Engelman A, Nurani R, Kurtzman SM, Lopez E, Chao M, Boike TP, Martinez AA, Gejerman G, Lederer J, Sylvester JE, Bell G, Rivera D, Shore N, Miller K, Sinayuk B, Steinberg ML, Low DA, Kishan AU, King MT. PMID: 36757690; PMCID: PMC9912169.
      View in: PubMed   Mentions: 8     Fields:    
    47. Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors. Urol Oncol. 2023 05; 41(5):253.e21-253.e26. Alshalalfa M, Goglia AG, Swami N, Nguyen B, Hougen HY, Khan A, Kishan AU, Punnen S, Nguyen PL, Mahal BA, Dee EC. PMID: 37003878; PMCID: PMC10559314.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer. NEJM Evid. 2023 Apr; 2(4):EVIDoa2200195. Gharzai LA, Jiang R, Jaworski EM, Morales Rivera K, Dess RT, Jackson WC, Hartman HE, Mehra R, Kishan AU, Solanki AA, Schaeffer EM, Feng FY, Zaorsky NG, Berlin A, Ponsky L, Shoag J, Sun Y, Schipper MJ, Garcia J, Spratt DE. PMID: 38320030.
      View in: PubMed   Mentions: 1  Translation:Humans
    49. Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era. Prostate Cancer Prostatic Dis. 2023 09; 26(3):625-627. Ma TM, Feng FY, Rosenthal SA, Rettig MB, Raldow AC, Spratt DE, Xiang M, Kishan AU. PMID: 36966268.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial. Radiother Oncol. 2023 06; 183:109631. Nikitas J, Smith LM, Gao Y, Ma TM, Sachdeva A, Yoon SM, Jiang T, Low DA, Ballas LK, Steinberg ML, Cao M, Kishan AU. PMID: 36934894.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    51. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol. 2023 06; 83(6):571-579. Roy S, Sun Y, Morgan SC, Wallis CJD, King K, Zhou YM, D'souza LA, Azem O, Cueto-Marquez AE, Camden NB, Spratt DE, Kishan AU, Saad F, Malone S. PMID: 36894488.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    52. Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol Oncol. 2023 04; 6(2):224-227. Smith CP, Proudfoot JA, Boutros PC, Reiter RE, Valle L, Rettig MB, Nickols NG, Feng FY, Nguyen PL, Nagar H, Spratt DE, Attard G, Weiner A, Weidhaas JB, Calais J, Ma TM, Davicioni E, Xiang M, Kishan AU. PMID: 36870853.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    53. LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol). BJU Int. 2023 07; 132(1):65-74. Ma TM, Czernin J, Felix C, Alano R, Wilhalme H, Valle L, Steinberg ML, Dahlbom M, Reiter RE, Rettig MB, Cao M, Calais J, Kishan AU. PMID: 36797449.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    54. Reply to A. Abner et al. J Clin Oncol. 2023 May 01; 41(13):2449-2450. Martin T, Sun Y, Spratt DE, Kishan AU. PMID: 36857621.
      View in: PubMed   Mentions:    Fields:    
    55. Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials. Int J Radiat Oncol Biol Phys. 2023 08 01; 116(5):1079-1084. Smith CP, Xiang M, Armstrong WR, Nickols NG, Steinberg ML, Reiter RE, Rettig M, Weiner AB, Shen J, Valle L, Czernin J, Calais J, Kishan AU. PMID: 36863416.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial. JAMA Oncol. 2023 03 01; 9(3):365-373. Kishan AU, Ma TM, Lamb JM, Casado M, Wilhalme H, Low DA, Sheng K, Sharma S, Nickols NG, Pham J, Yang Y, Gao Y, Neylon J, Basehart V, Cao M, Steinberg ML. PMID: 36633877; PMCID: PMC9857817.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    57. 68Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. J Nucl Med. 2023 06; 64(6):902-909. Sonni I, Dal Pra A, O'Connell DP, Ells Z, Benz M, Nguyen K, Yoon SM, Deng J, Smith C, Grogan T, Nickols NG, Cao M, Kishan AU, Calais J. PMID: 36759200; PMCID: PMC10241009.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial. Clin Transl Radiat Oncol. 2023 Mar; 39:100594. Kishan AU, Marco N, Ma TM, Steinberg ML, Sachdeva A, Cao M, Ballas LK, Rietdorf E, Telesca D, Weidhaas JB. PMID: 36880064; PMCID: PMC9984404.
      View in: PubMed   Mentions:
    59. Multimodality Therapies for Localized Prostate Cancer. Curr Oncol Rep. 2023 03; 25(3):221-229. Valle LF, Jiang T, Weiner AB, Reiter RE, Rettig MB, Shen J, Chang AJ, Nickols NG, Steinberg ML, Kishan AU. PMID: 36723856.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. Mask R-CNN assisted 2.5D object detection pipeline of 68Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging. Sci Rep. 2023 01 30; 13(1):1696. Xu D, Ma M, Cao M, Kishan AU, Nickols NG, Scalzo F, Sheng K. PMID: 36717727; PMCID: PMC9886937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy. Clin Genitourin Cancer. 2023 04; 21(2):208-212. Nikitas J, Cao M, Nickols NG, Valle L, Steinberg ML, Kishan AU. PMID: 36739178.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus. Int J Radiat Oncol Biol Phys. 2023 07 01; 116(3):503-520. Spohn SKB, Draulans C, Kishan AU, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra AD, de Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer LGW, Kirste S, Tselis N, Tran PT, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann NS, Wiegel T, Zilli T, Tree AC, Qiu X, Murthy V, Epstein JI, Graztke C, Gao X, Grosu AL, Kamran SC, Zamboglou C. PMID: 36596346.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19. Adv Radiat Oncol. 2022 Dec 12; 100924. Ma TM, Parikh NR, Philipson RG, van Dams R, Chang EM, Hegde JV, Kishan AU, Kaprealian TB, Steinberg ML, Raldow AC. PMID: 36532603; PMCID: PMC9744187.
      View in: PubMed   Mentions: 3  
    64. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments. Clin Transl Radiat Oncol. 2023 Jan; 38:161-168. Chuong MD, Clark MA, Henke LE, Kishan AU, Portelance L, Parikh PJ, Bassetti MF, Nagar H, Rosenberg SA, Mehta MP, Refaat T, Rineer JM, Smith A, Seung S, Zaki BI, Fuss M, Mak RH. PMID: 36466748; PMCID: PMC9712826.
      View in: PubMed   Mentions: 1  
    65. Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy? Clin Genitourin Cancer. 2023 06; 21(3):e93-e103. Arcos MBL, López-Campos F, Valcarcel ML, Rubio MG, de Manzanos IVF, Duque-Santana V, Aparicio MG, Martin JZ, Kishan AU, Achard V, Siva S, Couñago F. PMID: 36456467.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study. Adv Radiat Oncol. 2023 May-Jun; 8(3):101073. Ma TM, Yang T, Philipson R, Kishan AU, Lee P, Raldow AC. PMID: 37273926; PMCID: PMC10238265.
      View in: PubMed   Mentions:
    67. Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials. J Clin Oncol. 2023 02 01; 41(4):881-892. Ma TM, Sun Y, Malone S, Roach M, Dearnaley D, Pisansky TM, Feng FY, Sandler HM, Efstathiou JA, Syndikus I, Hall EC, Tree AC, Sydes MR, Cruickshank C, Roy S, Bolla M, Maingon P, De Reijke T, Nabid A, Carrier N, Souhami L, Zapatero A, Guerrero A, Alvarez A, Gonzalez San-Segundo C, Maldonado X, Romero T, Steinberg ML, Valle LF, Rettig MB, Nickols NG, Shoag JE, Reiter RE, Zaorsky NG, Jia AY, Garcia JA, Spratt DE, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. PMID: 36269935; PMCID: PMC9902004.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Editorial: Stereotactic body radiotherapy for prostate cancer. Front Oncol. 2022; 12:1034987. Kishan AU, Kaminski J, Alongi F. PMID: 36324568; PMCID: PMC9619069.
      View in: PubMed   Mentions:
    69. "Targeted microwave ablation: another way to kick the can(cer) down the road?" Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):635-636. Ma TM, Kishan AU. PMID: 36220855.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. Int J Radiat Oncol Biol Phys. 2023 03 01; 115(3):645-653. Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, DeWeese TL, Tilki D, Ciezki JP, Karnes RJ, Nickols NG, Rettig MB, Feng FY, Berlin A, Tward JD, Davis BJ, Reiter RE, Boutros PC, Romero T, Horwitz EM, Tendulkar RD, Steinberg ML, Spratt DE, Xiang M, Kishan AU. PMID: 36179990.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Fully automated segmentation of prostatic urethra for MR-guided radiation therapy. Med Phys. 2022 Sep 15. Xu D, Ma TM, Savjani R, Pham J, Cao M, Yang Y, Kishan AU, Scalzo F, Sheng K. PMID: 36106703.
      View in: PubMed   Mentions: 2     Fields:    
    72. Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE study. Prostate Cancer Prostatic Dis. 2023 03; 26(1):96-104. Roy S, Morgan SC, Wallis CJD, Sun Y, Spratt DE, Malone J, Grimes S, Mukherjee D, Kishan AU, Saad F, Malone S. PMID: 36097167.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology. Front Oncol. 2022; 12:962897. Hall WA, Kishan AU, Hall E, Nagar H, Vesprini D, Paulson E, Van der Heide UA, Lawton CAF, Kerkmeijer LGW, Tree AC. PMID: 36132128; PMCID: PMC9484536.
      View in: PubMed   Mentions:
    74. Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer. JAMA Netw Open. 2022 09 01; 5(9):e2231101. Brant A, Lewicki P, Xiang M, Zhu A, Kishan AU, Pollom EL, Shoag JE. PMID: 36094506; PMCID: PMC9468886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    75. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):142-152. Ma TM, Ballas LK, Wilhalme H, Sachdeva A, Chong N, Sharma S, Yang T, Basehart V, Reiter RE, Saigal C, Chamie K, Litwin MS, Rettig MB, Nickols NG, Yoon SM, Smith L, Gao Y, Steinberg ML, Cao M, Kishan AU. PMID: 36007724.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    76. Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN). Eur Urol. 2022 11; 82(5):487-498. Ma TM, Chu FI, Sandler H, Feng FY, Efstathiou JA, Jones CU, Roach M, Rosenthal SA, Pisansky T, Michalski JM, Bolla M, de Reijke TM, Maingon P, Neven A, Denham J, Steigler A, Joseph D, Nabid A, Souhami L, Carrier N, Incrocci L, Heemsbergen W, Pos FJ, Sydes MR, Dearnaley DP, Tree AC, Syndikus I, Hall E, Cruickshank C, Malone S, Roy S, Sun Y, Zaorsky NG, Nickols NG, Reiter RE, Rettig MB, Steinberg ML, Reddy VK, Xiang M, Romero T, Spratt DE, Kishan AU, Meta-analysis of Randomized trials in Cancer of the Prostate MARCAP Consortium investigators. PMID: 35934601.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    77. NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022. J Natl Compr Canc Netw. 2022 08; 20(8):866-878. Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. PMID: 35948037.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    78. Genomic biomarkers to guide precision radiotherapy in prostate cancer. Prostate. 2022 08; 82 Suppl 1:S73-S85. Sutera P, Deek MP, Van der Eecken K, Wyatt AW, Kishan AU, Molitoris JK, Ferris MJ, Siddiqui MM, Rana Z, Mishra MV, Kwok Y, Davicioni E, Spratt DE, Ost P, Feng FY, Tran PT. PMID: 35657158; PMCID: PMC9202472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Urethral Interfractional Geometric and Dosimetric Variations of Prostate Cancer Patients: A Study Using an Onboard MRI. Front Oncol. 2022; 12:916254. Pham J, Savjani RR, Yoon SM, Yang T, Gao Y, Cao M, Hu P, Sheng K, Low DA, Steinberg M, Kishan AU, Yang Y. PMID: 35912253; PMCID: PMC9334678.
      View in: PubMed   Mentions: 2  
    80. Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer. Prostate Cancer Prostatic Dis. 2023 03; 26(1):119-125. Roy S, Sun Y, Wallis CJD, Morgan SC, Grimes S, Malone J, Kishan AU, Mukherjee D, Spratt DE, Saad F, Malone S. PMID: 35790787.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    81. Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114. Eur Urol. 2022 09; 82(3):e82-e83. Kishan AU, Spratt DE. PMID: 35688665.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Adaptive Radiation Therapy Physician Guidelines: Recommendations From an Expert Users' Panel. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e355-e362. Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L. PMID: 35644469.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    83. Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy. Clin Oncol (R Coll Radiol). 2022 09; 34(9):581-588. Glicksman RM, Kishan AU, Quon H, Shabsovich D, Juarez J, Jiang T, Steinberg ML, Zhang L, Loblaw A. PMID: 35644708.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022 07; 82(1):106-114. Kishan AU, Wang X, Sun Y, Romero T, Michalski JM, Ma TM, Feng FY, Sandler HM, Bolla M, Maingon P, De Reijke T, Neven A, Steigler A, Denham JW, Joseph D, Nabid A, Carrier N, Souhami L, Sydes MR, Dearnaley DP, Syndikus I, Tree AC, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Efstathiou JA, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Xiang M, Rettig MB, Reiter RE, Zaorsky NG, Ong WL, Dess RT, Steinberg ML, Nickols NG, Roy S, Garcia JA, Spratt DE, MARCAP Consortium. PMID: 35469702.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. Developing a Mobile Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Administration System to Capture Postradiation Toxicity in Oncology: Usability and Feasibility Study. JMIR Form Res. 2022 Apr 12; 6(4):e27775. Underwood J, McCloskey S, Raldow A, Kishan A, Zalkin C, Navarro D, Holt LS, Webb A, Lynch KA, Atkinson TM. PMID: 35412466; PMCID: PMC9044154.
      View in: PubMed   Mentions: 2  
    86. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome. Front Oncol. 2022; 12:861127. Ryg U, Seierstad T, Nilsen LB, Hellebust TP, Djupvik LH, Gustafson H, Hydal J, Kishan AU, Hole KH, Lilleby W. PMID: 35463376; PMCID: PMC9022104.
      View in: PubMed   Mentions: 3  
    87. Dual X-ray Absorptiometry Screening for Men Receiving Androgen Deprivation Therapy-Hiding in Plain (Film) Sight. JAMA Netw Open. 2022 04 01; 5(4):e225439. Kishan AU, Kamran SC, Soerensen SJC, Leppert JT. PMID: 35363273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison. Adv Radiat Oncol. 2022 Jul-Aug; 7(4):100944. Wu TC, Xiang M, Nickols NG, Tenn S, Agazaryan N, Hegde JV, Steinberg ML, Cao M, Kishan AU. PMID: 35521072; PMCID: PMC9061255.
      View in: PubMed   Mentions:
    89. Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel. Front Oncol. 2022; 12:853246. Kundu P, Lin EY, Yoon SM, Parikh NR, Ruan D, Kishan AU, Lee A, Steinberg ML, Chang AJ. PMID: 35350564; PMCID: PMC8957858.
      View in: PubMed   Mentions: 1  
    90. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. JAMA Oncol. 2022 Mar 01; 8(3):e216871. Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Tosoian JJ, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Jiang T, Ma TM, Xiang M, Philipson R, Chang A, Kupelian PA, Rettig MB, Feng FY, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Boutros PC, Horwitz EM, Tendulkar RD, Spratt DE, Romero T. PMID: 35050303; PMCID: PMC8778608.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes. Clin Genitourin Cancer. 2022 08; 20(4):371-380. Labe SA, Wang X, Lehrer EJ, Kishan AU, Spratt DE, Lin C, Morgans AK, Ponsky L, Garcia JA, Garrett S, Wang M, Zaorsky NG. PMID: 35383004; PMCID: PMC9329179.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes. Cancers (Basel). 2022 Feb 14; 14(4). Woods KE, Ma TM, Cook KA, Morris ED, Gao Y, Sheng K, Kishan AU, Hegde JV, Felix C, Basehart V, Narahara K, Shen Z, Tenn S, Steinberg ML, Chin RK, Cao M. PMID: 35205686; PMCID: PMC8870161.
      View in: PubMed   Mentions: 2  
    93. Ensemble learning and tensor regularization for cone-beam computed tomography-based pelvic organ segmentation. Med Phys. 2022 Mar; 49(3):1660-1672. Zhou H, Cao M, Min Y, Yoon S, Kishan A, Ruan D. PMID: 35061244.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Technical note: Air bubble-induced performance degradation in automatic rectum segmentation from cone-beam CT. Med Phys. 2022 Mar; 49(3):1754-1758. Zhou H, Cao M, Ma M, Yoon S, Kishan A, Ruan D. PMID: 35015908.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. Prostate Cancer Prostatic Dis. 2023 03; 26(1):207-209. Kane N, Romero T, Diaz-Perez S, Rettig MB, Steinberg ML, Kishan AU, Schaue D, Reiter RE, Knudsen BS, Nickols NG. PMID: 35058580; PMCID: PMC10023555.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    96. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol. 2022 02; 23(2):304-316. Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A, Steigler A, Denham JW, Feng FY, Zapatero A, Armstrong JG, Nabid A, Carrier N, Souhami L, Dunne MT, Efstathiou JA, Sandler HM, Guerrero A, Joseph D, Maingon P, de Reijke TM, Maldonado X, Ma TM, Romero T, Wang X, Rettig MB, Reiter RE, Zaorsky NG, Steinberg ML, Nickols NG, Jia AY, Garcia JA, Spratt DE, MARCAP Consortium group. PMID: 35051385.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    97. Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types. Radiother Oncol. 2022 02; 167:308-316. Xiang M, Raldow AC, Pollom EL, Steinberg ML, Kishan AU. PMID: 35033605.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Clinicogenomic characterization of prostate cancer liver metastases. Prostate Cancer Prostatic Dis. 2022 02; 25(2):366-369. Alshalalfa M, Seldon C, Franco I, Vince R, Carmona R, Punnen S, Kaochar S, Dess R, Kishan A, Spratt DE, Sharma J, Dal Pra A, Pollack A, Abramowitz MC, Mahal BA. PMID: 35022600.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    99. Dosimetric Effects of Air Cavities for MRI-Guided Online Adaptive Radiation Therapy (MRgART) of Prostate Bed after Radical Prostatectomy. J Clin Med. 2022 Jan 12; 11(2). Pham J, Cao M, Yoon SM, Gao Y, Kishan AU, Yang Y. PMID: 35054061; PMCID: PMC8780446.
      View in: PubMed   Mentions: 2  
    100. Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know. Eur Urol. 2022 08; 82(2):149-151. Kerkmeijer LGW, Kishan AU, Tree AC. PMID: 35031164.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    101. Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics. Prostate Cancer Prostatic Dis. 2022 04; 25(4):713-719. Sutera P, Van Der Eecken K, Kishan AU, Hamid A, Grist E, Attard G, Lotan T, Mendes AA, Paller CJ, Carducci MA, Ross A, Wang H, Pienta K, Feng FY, Antonarakis ES, Ost P, Song DY, Greco S, Deville C, DeWeese T, Tran PT, Deek MP. PMID: 35013522; PMCID: PMC9310084.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    102. Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation. Radiother Oncol. 2022 02; 167:226-232. Kishan AU, Marco N, Schulz-Jaavall MB, Steinberg ML, Tran PT, Juarez JE, Dang A, Telesca D, Lilleby WA, Weidhaas JB. PMID: 34990726; PMCID: PMC8979583.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    103. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy. Radiother Oncol. 2022 02; 167:203-210. Ma TM, Neylon J, Casado M, Sharma S, Sheng K, Low D, Yang Y, Steinberg ML, Lamb J, Cao M, Kishan AU. PMID: 34979212.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    104. A personalized decision aid for prostate cancer shared decision making. BMC Med Inform Decis Mak. 2021 12 31; 21(1):374. Bagshaw HP, Martinez A, Heidari N, Scheinker D, Pollack A, Stoyanova R, Horwitz E, Morton G, Kishan AU, Buyyounouski MK. PMID: 34972513; PMCID: PMC8720209.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2022 06 01; 113(2):278-289. Roy S, Zaorsky NG, Bagshaw HP, Berlin A, Tree A, Turner S, Koontz B, Nguyen P, Chen R, Dess RT, Jackson WC, Kishan AU, Stish B, Nagar H, Posadas E, Tran PT, Solanki A, Shore ND, Guo G, Ponsky L, Shoag JE, Morgans AK, Garcia JA, Showalter TN, Feng FY, Spratt DE. PMID: 34923058.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    106. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. JAMA Netw Open. 2021 12 01; 4(12):e2138550. Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Huland H, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, Rettig MB, Zaorsky NG, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D, Czernin J, Gafita A, Romero T, Calais J, Kishan AU. PMID: 34902034; PMCID: PMC8669522.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. JAMA Netw Open. 2021 12 01; 4(12):e2139769. Ma TM, Romero T, Nickols NG, Rettig MB, Garraway IP, Roach M, Michalski JM, Pisansky TM, Lee WR, Jones CU, Rosenthal SA, Wang C, Hartman H, Nguyen PL, Feng FY, Boutros PC, Saigal C, Chamie K, Jackson WC, Morgan TM, Mehra R, Salami SS, Vince R, Schaeffer EM, Mahal BA, Dess RT, Steinberg ML, Elashoff D, Sandler HM, Spratt DE, Kishan AU. PMID: 34964855; PMCID: PMC8717118.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    108. Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. Clin Oncol (R Coll Radiol). 2022 01; 34(1):36-41. Glicksman RM, Kishan AU, Katz AJ, Mantz CA, Collins SP, Fuller DB, Steinberg ML, Shabsovich D, Zhang L, Loblaw A. PMID: 34836735.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. CA Cancer J Clin. 2022 01; 72(1):34-56. Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD. PMID: 34792808; PMCID: PMC8985054.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    110. Bladder surface dose modeling in prostate cancer radiotherapy: An analysis of motion-induced variations and the cumulative dose across the treatment. Med Phys. 2021 Dec; 48(12):8024-8036. Lao Y, Cao M, Yang Y, Kishan AU, Yang W, Wang Y, Sheng K. PMID: 34734414; PMCID: PMC8683601.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer. Clin Genitourin Cancer. 2022 04; 20(2):e94-e103. Xiang M, Chang AJ, Chamie K, Drakaki A, Pollom EL, Steinberg ML, Kishan AU. PMID: 34866018.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2022 01; 166:1-7. Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. PMID: 34774650.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    113. Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT. Appl Radiat Oncol. 2021 Sep; 10(3):33-40. Parikh NR, Clark MA, Patel P, Kafka-Peterson K, Zaide L, Ma TM, Steinberg ML, Cao M, Raldow AC, Lamb J, Kishan AU. PMID: 34671700; PMCID: PMC8525878.
      View in: PubMed   Mentions: 5  
    114. Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). Cancer Genet. 2021 11; 258-259:61-68. Swami N, Hwang WL, Guo JA, Hoffman H, Abramowitz MC, Elbakouny Z, Beltran H, Chipidza F, Choueiri T, Pra AD, Huang F, Kaochar S, Kantoff P, Kim DW, Kishan AU, Kobetz E, Marinac C, Mucci LA, Muralidhar V, Pollack A, Sanford NN, Schaeffer EM, Spratt DE, Zhao SG, Rebbeck TR, Nguyen PL, Feng FY, Mahal BA, Alshalalfa M. PMID: 34551377.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    115. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Adv Radiat Oncol. 2021 Nov-Dec; 6(6):100759. Juarez JE, Romero T, Mantz CA, Pepin A, Aghdam N, Suy S, Steinberg ML, Levin-Epstein RG, Nickols NG, Kaplan ID, Meier RM, Pham HT, Linson PW, Hong RL, Buyyounouski MK, Bagshaw HP, Fuller DB, Katz AJ, Loblaw A, Collins SP, Kishan AU. PMID: 34585025; PMCID: PMC8453194.
      View in: PubMed   Mentions: 2  
    116. Pan-cancer analysis of prognostic metastatic phenotypes. Int J Cancer. 2022 01 01; 150(1):132-141. Zaorsky NG, Wang X, Garrett SM, Lehrer EJ, Lin C, DeGraff DJ, Spratt DE, Trifiletti DM, Kishan AU, Showalter TN, Park HS, Yang JT, Chinchilli VM, Wang M. PMID: 34287840; PMCID: PMC8595638.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    117. Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials. Prostate Cancer Prostatic Dis. 2022 03; 25(1):126-128. Jiang T, Markovic D, Patel J, Juarez JE, Ma TM, Shabsovich D, Nickols NG, Reiter RE, Elashoff D, Rettig MB, Zaorsky NG, Spratt DE, Kishan AU. PMID: 34400799; PMCID: PMC9018418.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    118. Salvage therapy for prostate cancer after radical prostatectomy. Nat Rev Urol. 2021 11; 18(11):643-668. Zaorsky NG, Calais J, Fanti S, Tilki D, Dorff T, Spratt DE, Kishan AU. PMID: 34363040.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    119. Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI. Cancers (Basel). 2021 Jul 16; 13(14). Pham J, Savjani RR, Gao Y, Cao M, Hu P, Sheng K, Low DA, Steinberg M, Kishan AU, Yang Y. PMID: 34298777; PMCID: PMC8307202.
      View in: PubMed   Mentions: 5  
    120. Clinical assessment of geometric distortion for a 0.35T MR-guided radiotherapy system. J Appl Clin Med Phys. 2021 Aug; 22(8):303-309. Neylon J, Cook KA, Yang Y, Du D, Sheng K, Chin RK, Kishan AU, Lamb JM, Low DA, Cao M. PMID: 34231963; PMCID: PMC8364259.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    121. Quality of Life After Prostate Cancer Treatment. Int J Radiat Oncol Biol Phys. 2021 07 01; 110(3):727-730. Kishan AU, Collins SP. PMID: 34089679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    122. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. JAMA Netw Open. 2021 07 01; 4(7):e2115312. Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S, Martínez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Chang AJ, Pisansky TM, Choo R, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, D'Amico AV, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D. PMID: 34196715; PMCID: PMC8251338.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Simulated consult and treatment exercise improves radiation oncology trainee confidence and knowledge. J Educ Health Promot. 2021; 10:218. Valle LF, Kundu P, Yoon SM, Pennington JD, Cao M, Lee PP, Kishan AU. PMID: 34395655; PMCID: PMC8318145.
      View in: PubMed   Mentions: 1  
    124. Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer. J Pers Med. 2021 Jun 26; 11(7). Guldvik IJ, Ekseth L, Kishan AU, Stensvold A, Inderberg EM, Lilleby W. PMID: 34206815; PMCID: PMC8303369.
      View in: PubMed   Mentions: 1  
    125. Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial. Radiother Oncol. 2022 05; 170:14-20. van Dams R, Wu TC, Kishan AU, Raldow AC, Chu FI, Hernandez J, Cao M, Lamb JM, Mikaeilian A, Low DA, Steinberg ML, Lee P. PMID: 34107296.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    126. Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial. Cancers (Basel). 2021 Jun 04; 13(11). Cao M, Gao Y, Yoon SM, Yang Y, Sheng K, Ballas LK, Basehart V, Sachdeva A, Felix C, Low DA, Steinberg ML, Kishan AU. PMID: 34199881; PMCID: PMC8200117.
      View in: PubMed   Mentions: 5  
    127. PSA bounce, prognosis, and clues to the radiation response. Prostate Cancer Prostatic Dis. 2021 12; 24(4):937-938. Kishan AU. PMID: 34007012.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial. BMC Cancer. 2021 May 11; 21(1):538. Ma TM, Lamb JM, Casado M, Wang X, Basehart TV, Yang Y, Low D, Sheng K, Agazaryan N, Nickols NG, Cao M, Steinberg ML, Kishan AU. PMID: 33975579; PMCID: PMC8114498.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    129. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. Eur Urol. 2021 08; 80(2):142-146. Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Klein EA, Tosoian JJ, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Kupelian PA, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Kishan AU. PMID: 33985797; PMCID: PMC10262978.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    130. Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol. BMC Cancer. 2021 May 07; 21(1):512. Calais J, Zhu S, Hirmas N, Eiber M, Hadaschik B, Stuschke M, Herrmann K, Czernin J, Kishan AU, Nickols NG, Elashoff D, Fendler WP. PMID: 33962579; PMCID: PMC8103642.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    131. Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010. Eur Urol. 2021 07; 80(1):e15-e16. Valle LF, Kishan AU. PMID: 33934928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. Automated Non-Coplanar VMAT for Dose Escalation in Recurrent Head and Neck Cancer Patients. Cancers (Basel). 2021 Apr 15; 13(8). Woods K, Chin RK, Cook KA, Sheng K, Kishan AU, Hegde JV, Tenn S, Steinberg ML, Cao M. PMID: 33921062; PMCID: PMC8071369.
      View in: PubMed   Mentions: 5  
    133. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Eur Urol. 2021 06; 79(6):717-721. Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, Carroll PR, Schaeffer E, Feng FY. PMID: 33840559.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    134. Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis. Lancet Oncol. 2021 03; 22(3):402-410. Gharzai LA, Jiang R, Wallington D, Jones G, Birer S, Jairath N, Jaworski EM, McFarlane MR, Mahal BA, Nguyen PL, Sandler H, Morgan TM, Reichert ZR, Alumkal JJ, Mehra R, Kishan AU, Fizazi K, Halabi S, Schaeffer EM, Feng FY, Elliott D, Dess RT, Jackson WC, Schipper MJ, Spratt DE. PMID: 33662287; PMCID: PMC10949134.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    135. Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review. Eur Urol Oncol. 2021 06; 4(3):339-355. Valle L, Shabsovich D, de Meerleer G, Maurer T, Murphy DG, Nickols NG, Vapiwala N, Calais J, Kishan AU. PMID: 33637464.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    136. Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. Eur Urol Oncol. 2022 02; 5(1):100-103. Ma TM, Gafita A, Shabsovich D, Juarez J, Grogan TR, Thin P, Armstrong W, Sonni I, Nguyen K, Lok V, Reiter RE, Rettig MB, Steinberg ML, Kupelian PA, Yang DD, Muralidhar V, Chu C, Feng F, Savjani R, Deng J, Parikh NR, Nickols NG, Elashoff D, Czernin J, Calais J, Kishan AU. PMID: 33602654; PMCID: PMC10262977.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    137. Multi-task edge-recalibrated network for male pelvic multi-organ segmentation on CT images. Phys Med Biol. 2021 01 26; 66(3):035001. Tong N, Gou S, Chen S, Yao Y, Yang S, Cao M, Kishan A, Sheng K. PMID: 33197901.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    138. Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. Int J Radiat Oncol Biol Phys. 2021 07 01; 110(3):731-737. van Dams R, Jiang NY, Fuller DB, Loblaw A, Jiang T, Katz AJ, Collins SP, Aghdam N, Suy S, Stephans KL, Yuan Y, Nickols NG, Murthy V, Telkhade TP, Kupelian PA, Steinberg ML, Romero T, Kishan AU. PMID: 33493615; PMCID: PMC8956505.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    139. A Practical Guide for Navigating the Design, Build, and Clinical Integration of Electronic Patient-Reported Outcomes in the Radiation Oncology Department. Pract Radiat Oncol. 2021 Jul-Aug; 11(4):e376-e383. Philipson RG, Wu AD, Curtis WC, Jablonsky DJ, Hegde JV, McCloskey SA, Kaprealian TB, Steinberg ML, Kishan AU, Raldow AC. PMID: 33460827.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    140. The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited. Eur Urol. 2021 11; 80(5):632-640. Deek MP, Van der Eecken K, Phillips R, Parikh NR, Isaacsson Velho P, Lotan TL, Kishan AU, Maurer T, GAP6 Consortium, Boutros PC, Hovens C, Abramowtiz M, Pollack A, Desai N, Stish B, Feng FY, Eisenberger M, Carducci M, Pienta KJ, Markowski M, Paller CJ, Antonarakis ES, Berlin A, Ost P, Tran PT. PMID: 33419682; PMCID: PMC10262980.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    141. Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome. Eur Urol Focus. 2021 03; 7(2):238-240. Calais J, Armstrong WR, Kishan AU, Booker KM, Hope TA, Fendler WP, Elashoff D, Nickols NG, Czernin J. PMID: 33386288; PMCID: PMC8057677.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    142. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. 2021 09; 80(3):280-292. Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, Reiter RE, Rettig M, Calais J, Nickols NG, Dess RT, Spratt DE, Steinberg ML, Nguyen PL, Davis BJ, Zaorsky NG, Kishan AU. PMID: 33309278; PMCID: PMC10262981.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    143. MR-Guided Radiotherapy for Prostate Cancer. Front Oncol. 2020; 10:616291. Tocco BR, Kishan AU, Ma TM, Kerkmeijer LGW, Tree AC. PMID: 33363041; PMCID: PMC7757637.
      View in: PubMed   Mentions: 31  
    144. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021 03; 79(3):374-383. Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. PMID: 33293078.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    145. Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis. J Clin Oncol. 2021 01 10; 39(2):136-144. Spratt DE, Malone S, Roy S, Grimes S, Eapen L, Morgan SC, Malone J, Craig J, Dess RT, Jackson WC, Hartman HE, Kishan AU, Mehra R, Kaffenberger S, Morgan TM, Reichert ZR, Alumkal JJ, Michalski J, Lee WR, Pisansky TM, Feng FY, Shipley W, Sandler HM, Schipper MJ, Roach M, Sun Y, Lawton CAF. PMID: 33275486; PMCID: PMC8189640.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    146. Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy. Cancers (Basel). 2020 Dec 02; 12(12). Ma TM, Lilleby O, Lilleby WA, Kishan AU. PMID: 33276562; PMCID: PMC7761604.
      View in: PubMed   Mentions: 2  
    147. Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 04 01; 109(5):1279-1285. Dee EC, Muralidhar V, Arega MA, Kishan AU, Spratt DE, Dess RT, King MT, Sha ST, Santos PMG, Butler SS, Sanford NN, Nguyen PL, Mahal BA. PMID: 33276019.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    148. Stereotactic body radiation therapy use for high risk prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2021 06; 24(2):578-581. Patel SA, Switchenko JM, Kishan AU, Jani AB, Royce TJ, Fischer-Valuck BW. PMID: 33188271; PMCID: PMC8116349.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    149. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Adv Radiat Oncol. 2020 Nov; 5(Suppl 1):26-32. Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, Mitin T, Tree A, Kishan AU, Spratt DE. PMID: 33145460; PMCID: PMC7598436.
      View in: PubMed   Mentions: 12  
    150. Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2021 03 15; 109(4):953-963. Dinh TT, Mitin T, Bagshaw HP, Hoffman KE, Hwang C, Jeffrey Karnes R, Kishan AU, Liauw SL, Lloyd S, Potters L, Showalter TN, Taira AV, Vapiwala N, Zaorsky NG, D'Amico AV, Nguyen PL, Davis BJ. PMID: 33127490.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    151. Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology. Int J Radiat Oncol Biol Phys. 2021 03 15; 109(4):1054-1075. Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, Parker W, Doemer A, Rong Y, Kishan AU, Benedict SH, Li XA, Erickson BA, Sohn JW, Xiao Y, Wuthrick E. PMID: 33470210; PMCID: PMC8290862.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    152. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images. Med Phys. 2020 Dec; 47(12):6405-6413. Singhrao K, Fu J, Parikh NR, Mikaeilian AG, Ruan D, Kishan AU, Lewis JH. PMID: 32989773.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    153. Prostate-specific Membrane Antigen Positron Emission Tomography-guided Radiotherapy. Eur Urol Focus. 2021 03; 7(2):250-253. Kishan AU, Nickols NG, Spratt DE. PMID: 33046413.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    154. Impact of Health-related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice in Low- and Intermediate-Risk Prostate Cancer. Eur Urol Open Sci. 2020 Oct; 21:69-76. Riskin-Jones H, Grogan T, Kishan A, Raldow A. PMID: 34337470; PMCID: PMC8317816.
      View in: PubMed   Mentions:
    155. Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. Radiother Oncol. 2021 01; 154:207-213. Levin-Epstein RG, Jiang NY, Wang X, Upadhyaya SK, Collins SP, Suy S, Aghdam N, Mantz C, Katz AJ, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas N, Bagshaw H, Buyyounouski MK, Cao M, Agazaryan N, Dang A, Yuan Y, Kupelian PA, Zaorsky NG, Spratt DE, Mohamad O, Feng FY, Mahal BA, Boutros PC, Kishan AU, Juarez J, Shabsovich D, Jiang T, Kahlon S, Patel A, Patel J, Nickols NG, Steinberg ML, Fuller DB, Kishan AU. PMID: 33035622; PMCID: PMC7956167.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    156. Time-Driven Activity-Based Costing Analysis of Telemedicine Services in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2020 10 01; 108(2):430-434. Parikh NR, Chang EM, Kishan AU, Kaprealian TB, Steinberg ML, Raldow AC. PMID: 32890526; PMCID: PMC7462887.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    157. Local failure in high grade prostate cancer: the importance of local and systemic therapy. Transl Androl Urol. 2020 Oct; 9(5):2315-2317. Kishan AU, Sandler HM. PMID: 33209704; PMCID: PMC7658116.
      View in: PubMed   Mentions:
    158. Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer. Transl Androl Urol. 2020 Oct; 9(5):2326-2328. Cook K, Kishan AU. PMID: 33209705; PMCID: PMC7658165.
      View in: PubMed   Mentions:
    159. Analysis of Geometric Performance and Dosimetric Impact of Using Automatic Contour Segmentation for Radiotherapy Planning. Front Oncol. 2020; 10:1762. Cao M, Stiehl B, Yu VY, Sheng K, Kishan AU, Chin RK, Yang Y, Ruan D. PMID: 33102206; PMCID: PMC7546883.
      View in: PubMed   Mentions: 9  
    160. The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer. Adv Radiat Oncol. 2020 Nov-Dec; 5(6):1364-1369. Parikh NR, Tsai S, Bennett C, Lewis M, Sadeghi A, Lorentz W, Cheung M, Garraway I, Aronson W, Kishan AU, Bahri S, Vahidi K, Calais J, Ishimitsu D, Rettig M, Nickols NG, Jafari L. PMID: 33305100; PMCID: PMC7718503.
      View in: PubMed   Mentions:
    161. Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2020 09 01; 3(9):e2017144. Nguyen KA, Lee A, Patel SA, Chakravorty A, Yu JB, Kishan AU, Chang AJ. PMID: 32970153; PMCID: PMC7516602.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    162. Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options. Front Oncol. 2020; 10:1616. Zaorsky NG, Spratt DE, Kishan AU, Culp SH, Showalter TN. PMID: 32984028; PMCID: PMC7481351.
      View in: PubMed   Mentions: 1  
    163. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2021 02; 48(2):501-508. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077; PMCID: PMC7835157.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    164. Practical Safety Considerations for Integration of Magnetic Resonance Imaging in Radiation Therapy. Pract Radiat Oncol. 2020 Nov - Dec; 10(6):443-453. Hu Q, Yu VY, Yang Y, Hu P, Sheng K, Lee PP, Kishan AU, Raldow AC, O'Connell DP, Woods KE, Cao M. PMID: 32781246; PMCID: PMC8472473.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    165. Acute toxicities after extremely hypofractionated radiotherapy for prostate cancer: lessons from HYPO-RT-PC and PACE-B. Transl Cancer Res. 2020 Aug; 9(8):4469-4472. Juarez JE, Kishan AU. PMID: 35117811; PMCID: PMC8797873.
      View in: PubMed   Mentions: 2  
    166. Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. Radiother Oncol. 2020 10; 151:26-32. Levin-Epstein R, Cook RR, Wong JK, Stock RG, Jeffrey Demanes D, Collins SP, Aghdam N, Suy S, Mantz C, Katz AJ, Nickols NG, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas ND, Bagshaw H, Buyyounouski MK, Cao M, Mahal BA, Shabsovich D, Dang A, Yuan Y, Rettig MB, Chang AJ, Jackson WC, Spratt DE, Lehrer EJ, Zaorsky NG, Kupelian PA, Steinberg ML, Horwitz EM, Jiang NY, Kishan AU. PMID: 32663537.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    167. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells. Prostate Cancer Prostatic Dis. 2021 03; 24(1):135-139. Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D. PMID: 32647353; PMCID: PMC7794088.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    168. PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics. Clin Nucl Med. 2020 Jul; 45(7):e309-e310. Sonni I, Caron J, Kishan AU, Muthusamy VR, Calais J. PMID: 32404709.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    169. Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):930-935. Parikh NR, Kishan AU, Kane N, Diaz-Perez S, Ganapathy E, Nazarian R, Felix C, Mathis C, Bradley M, Sachdeva A, Wyatt B, Basehart V, Zomorodian N, Lin L, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Elashoff D, Schaue D, Reiter RE, Nickols NG. PMID: 32562839; PMCID: PMC8261839.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    170. Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy. Adv Radiat Oncol. 2020 Nov-Dec; 5(6):1334-1341. Qi XS, Chu FI, Zhang Z, Chin RK, Raldow A, Kishan AU, Lee P, Chang A, Kalbasi A, Kamrava M, Steinberg ML, Low DA. PMID: 33305096; PMCID: PMC7718556.
      View in: PubMed   Mentions:
    171. Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):917-926. Parikh NR, Chang EM, Nickols NG, Rettig MB, Raldow AC, Steinberg ML, Koontz BF, Vapiwala N, Deville C, Feng FY, Spratt DE, Reiter RE, Phillips R, Ost P, Tran PT, Kishan AU. PMID: 32544574.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    172. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. Eur Urol. 2020 09; 78(3):327-332. Kishan AU, Romero T, Alshalalfa M, Liu Y, Tran PT, Nickols NG, Ye H, Sajed D, Rettig MB, Reiter RE, Garraway IP, Spratt DE, Freedland SJ, Zhao X, Li Z, Deek M, Livingstone J, Mahal BA, Nguyen PL, Feng FY, Den RB, Schaeffer EM, Lotan TL, Karnes RJ, Klein EA, Ross AE, Grogan T, Davicioni E, Elashoff D, Boutros PC, Weidhaas JB. PMID: 32461072; PMCID: PMC8954568.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    173. Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy. Front Oncol. 2020; 10:786. Valle LF, Ruan D, Dang A, Levin-Epstein RG, Patel AP, Weidhaas JB, Nickols NG, Lee PP, Low DA, Qi XS, King CR, Steinberg ML, Kupelian PA, Cao M, Kishan AU. PMID: 32509582; PMCID: PMC7251156.
      View in: PubMed   Mentions: 1  
    174. Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials. J Clin Oncol. 2020 09 10; 38(26):3024-3031. Jackson WC, Hartman HE, Dess RT, Birer SR, Soni PD, Hearn JWD, Reichert ZR, Kishan AU, Mahal BA, Zumsteg ZS, Efstathiou JA, Kaffenberger S, Morgan TM, Mehra R, Showalter TN, Krauss DA, Nguyen PL, Schipper MJ, Feng FY, Sandler HM, Hoskin PJ, Roach M, Spratt DE. PMID: 32396488; PMCID: PMC8265327.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    175. Stereotactic Body Radiotherapy for Prostate Cancer. Am J Mens Health. 2020 May-Jun; 14(3):1557988320927241. Parikh NR, Kishan AU. PMID: 32500805; PMCID: PMC7278320.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    176. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. JAMA Oncol. 2020 05 01; 6(5):735-743. Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE. PMID: 32215583; PMCID: PMC7189892.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    177. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials. Radiother Oncol. 2020 07; 148:235-242. Lehrer EJ, Kishan AU, Yu JB, Trifiletti DM, Showalter TN, Ellis R, Zaorsky NG. PMID: 32505965.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    178. Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose-volume histogram using ensemble machine learning. Radiother Oncol. 2020 07; 148:181-188. Pan X, Levin-Epstein R, Huang J, Ruan D, King CR, Kishan AU, Steinberg ML, Qi XS. PMID: 32388444.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    179. Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer. Front Oncol. 2020; 10:539. Levin-Epstein R, Qiao-Guan G, Juarez JE, Shen Z, Steinberg ML, Ruan D, Valle L, Nickols NG, Kupelian PA, King CR, Cao M, Kishan AU. PMID: 32373529; PMCID: PMC7177009.
      View in: PubMed   Mentions: 15  
    180. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy. Radiother Oncol. 2020 07; 148:44-50. Yoon S, Cao M, Aghdam N, Shabsovich D, Kahlon S, Ballas L, Collins S, Steinberg ML, Kishan AU. PMID: 32311600.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    181. Salvage therapy at biochemical recurrence of prostate cancer. Nat Rev Urol. 2020 04; 17(4):195-196. Zaorsky NG, Kishan AU. PMID: 32051611.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    182. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Adv Radiat Oncol. 2020 Jul-Aug; 5(4):659-665. Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, Mitin T, Tree A, Kishan AU, Spratt DE. PMID: 32292839; PMCID: PMC7118610.
      View in: PubMed   Mentions: 86  
    183. Caught Between a Rock and a Hard Place. Int J Radiat Oncol Biol Phys. 2021 03 15; 109(4):846-847. Kishan AU, Reiter RE. PMID: 32173187.
      View in: PubMed   Mentions:    Fields:    
    184. A novel anthropomorphic multimodality phantom for MRI-based radiotherapy quality assurance testing. Med Phys. 2020 Apr; 47(4):1443-1451. Singhrao K, Fu J, Wu HH, Hu P, Kishan AU, Chin RK, Lewis JH. PMID: 31954078.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    185. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation. Phys Med Biol. 2020 02 05; 65(3):035015. Singhrao K, Ruan D, Fu J, Gao Y, Chee G, Yang Y, King C, Hu P, Kishan AU, Lewis JH. PMID: 31881546.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study. J Nucl Med. 2020 08; 61(8):1153-1160. Sonni I, Eiber M, Fendler WP, Alano RM, Vangala SS, Kishan AU, Nickols N, Rettig MB, Reiter RE, Czernin J, Calais J. PMID: 31924715; PMCID: PMC7413232.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    187. Optimal patient selection for stereotactic body radiotherapy. Lancet Oncol. 2019 12; 20(12):e661. Kishan AU, Collins SP, Nickols NG. PMID: 31797787.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    188. Addition of Chemotherapy Is Associated With Decreased Survival in Early-Stage (T1-2N0M0) Glottic Squamous Cell Carcinoma Treated With Definitive Radiotherapy. JCO Precis Oncol. 2019 Dec; 3:1-14. Wang C, Kishan AU, Raldow A, Beron P, Wong DJ, St John M, Steinberg ML, Chin R. PMID: 35100668.
      View in: PubMed   Mentions: 1     Fields:    
    189. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 02; 77(2):201-208. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. PMID: 31718822; PMCID: PMC7008470.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    190. ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. J Am Coll Radiol. 2019 Nov; 16(11S):S399-S416. Expert Panel on Urological Imaging, Purysko AS, Nikolaidis P, Dogra VS, Ganeshan D, Gore JL, Gupta RT, Heilbrun ME, Khatri G, Kishan AU, Lyshchik A, Savage SJ, Smith AD, Wang ZJ, Wolfman DJ, Wong-You-Cheong JJ, Yoo DC, Lockhart ME. PMID: 31685108.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    191. Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Adv Radiat Oncol. 2020 May-Jun; 5(3):404-411. Dang AT, Levin-Epstein RG, Shabsovich D, Cao M, King C, Chu FI, Mantz CA, Stephans KL, Reddy CA, Loblaw DA, Cheung P, Scorsetti M, Cozzi L, DeNittis AS, Wang Y, Zaorsky N, Nickols NG, Kupelian PA, Steinberg ML, Kishan AU. PMID: 32529134; PMCID: PMC7276661.
      View in: PubMed   Mentions: 2  
    192. Androgen deprivation therapy in high risk prostate cancer. Transl Cancer Res. 2019 Sep; 8(5):2216-2217. Van Dams R, Kishan AU. PMID: 35116972; PMCID: PMC8798048.
      View in: PubMed   Mentions:
    193. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469; PMCID: PMC7469487.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCTClinical Trials
    194. Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 11 01; 105(3):628-636. Jiang NY, Dang AT, Yuan Y, Chu FI, Shabsovich D, King CR, Collins SP, Aghdam N, Suy S, Mantz CA, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw H, Prionas N, Buyyounouski MK, Jackson WC, Spratt DE, Nickols NG, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31276777.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    195. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. JAMA Oncol. 2019 07 01; 5(7):975-983. Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE. PMID: 31120534; PMCID: PMC6547116.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCTClinical Trials
    196. Key considerations when reviewing subsequent primary cancers following radiotherapy. Lancet Oncol. 2019 06; 20(6):e291. Kishan AU, Wang C, Steinberg ML, Spratt DE. PMID: 31162098.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    197. Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):149-154. Yuan Y, Aghdam N, King CR, Fuller DB, Weng J, Chu FI, Mardirossian G, Patel A, Nickols NG, Kupelian PA, Steinberg ML, Collins SP, Kishan AU. PMID: 31108142.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    198. Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014). Adv Radiat Oncol. 2019 Oct-Dec; 4(4):738-747. Wang C, Kishan AU, Yu JB, Raldow A, King CR, Iwamoto KS, Chu FI, Steinberg ML, Kupelian PA. PMID: 31673667; PMCID: PMC6817555.
      View in: PubMed   Mentions: 4  
    199. The current state of randomized clinical trial evidence for prostate brachytherapy. Urol Oncol. 2019 09; 37(9):599-610. Dess RT, Soni PD, Jackson WC, Berlin A, Cox BW, Jolly S, Efstathiou JA, Feng FY, Kishan AU, Stish BJ, Pisansky TM, Spratt DE. PMID: 31060795.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    200. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Eur Urol. 2020 01; 77(1):3-10. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 30992160; PMCID: PMC7521828.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    201. Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):778-789. Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, Gharzai LA, Jaworski EM, Mehra R, Hearn JWD, Morgan TM, Salami SS, Cooperberg MR, Mahal BA, Soni PD, Kaffenberger S, Nguyen PL, Desai N, Feng FY, Zumsteg ZS, Spratt DE. PMID: 30959121; PMCID: PMC6770993.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    202. Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial. Br J Radiol. 2019 Jul; 92(1099):20181001. Kishan AU, Tyran M, Weng J, Upadhyaya S, Lamb J, Steinberg M, King C, Cao M. PMID: 30912957; PMCID: PMC6636273.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    203. Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. BMC Cancer. 2019 Apr 01; 19(1):291. Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG. PMID: 30935383; PMCID: PMC6444674.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    204. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2021 04; 4(2):327-330. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31411981.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    205. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2019 02 01; 2(2):e188006. Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. PMID: 30735235; PMCID: PMC6484596.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    206. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? Eur Urol. 2019 05; 75(5):e133-e134. Kishan AU, Hall WA, Spratt DE. PMID: 30670312.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    207. Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis. JAMA Oncol. 2019 01 01; 5(1):91-96. Kishan AU, Wang X, Seiferheld W, Collette L, Sandler KA, Sandler HM, Bolla M, Maingon P, De Reijke T, Hanks GE, Nickols NG, Rettig M, Drakaki A, Reiter RE, Spratt DE, Kupelian PA, Steinberg ML, King CR. PMID: 30326032; PMCID: PMC6440243.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    208. Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):50-60. Ballas LK, Luo C, Chung E, Kishan AU, Shuryak I, Quinn DI, Dorff T, Jhimlee S, Chiu R, Abreu A, Jennelle R, Aron M, Groshen S. PMID: 30605751; PMCID: PMC7457432.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    209. Treatment of the primary tumor in metastatic prostate cancer. World J Urol. 2019 Dec; 37(12):2597-2606. Yuan Y, Kishan AU, Nickols NG. PMID: 30456709.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    210. Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8: Setting the Standard: The Importance of Defining the Standard of Care for Comparative Effectiveness Analyses. Eur Urol Oncol. 2019 03; 2(2):224-225. Kishan AU, Cook RR, King CR. PMID: 31017101.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    211. Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer. Am J Clin Oncol. 2018 09; 41(9):898-904. Shaverdian N, Kishan AU, Veruttipong D, Demanes DJ, Kupelian P, McCloskey S, Steinberg ML, King CR. PMID: 28537990.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    212. Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer. Am J Clin Oncol. 2018 08; 41(8):739-746. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Kishan AU, Saigal C, Rettig M, Steinberg ML, King CR. PMID: 28301348.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    213. Optimal Treatment for High-Risk Prostate Cancer-Reply. JAMA. 2018 07 24; 320(4):405. Kishan AU, Cook RR, King CR. PMID: 30043055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    214. Image-guided radiotherapy for prostate cancer. Transl Androl Urol. 2018 Jun; 7(3):308-320. Dang A, Kupelian PA, Cao M, Agazaryan N, Kishan AU. PMID: 30050792; PMCID: PMC6043755.
      View in: PubMed   Mentions: 27  
    215. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer? Am J Clin Oncol. 2018 06; 41(6):549-557. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Saigal C, Rettig M, Steinberg ML, King CR. PMID: 27560157.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    216. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):3-18. Kishan AU, Tendulkar RD, Tran PT, Parker CC, Nguyen PL, Stephenson AJ, Carrie C. PMID: 31100226.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    217. Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer. J Nucl Med. 2018 11; 59(11):1714-1721. Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. PMID: 29653978; PMCID: PMC6225538.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    218. Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer. Cureus. 2018 Apr 06; 10(4):e2442. Hegde JV, Cao M, Yu VY, Kishan AU, Shaverdian N, Lamb J, Steinberg ML. PMID: 29881655; PMCID: PMC5990029.
      View in: PubMed   Mentions: 4  
    219. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):883-888. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 29976500.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    220. MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer. Cureus. 2018 Mar 22; 10(3):e2360. Kishan AU, Tyran M, Steinberg ML, Holden SB, Cao M. PMID: 29805929; PMCID: PMC5963943.
      View in: PubMed   Mentions: 2  
    221. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA. 2018 03 06; 319(9):896-905. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 29509865; PMCID: PMC5885899.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    222. Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT. Br J Radiol. 2018 Feb; 91(1083):20170522. Thomas DH, Santhanam A, Kishan AU, Cao M, Lamb J, Min Y, O'Connell D, Yang Y, Agazaryan N, Lee P, Low D. PMID: 29166129; PMCID: PMC5965474.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    223. Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2018 03; 166:116-123. Nguyen T, Duong C, Sheppard JP, Lee SJ, Kishan AU, Lee P, Tenn S, Chin R, Kaprealian TB, Yang I. PMID: 29414150.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    224. Comparison of lung tumor motion measured using a model-based 4DCT technique and a commercial protocol. Pract Radiat Oncol. 2018 May - Jun; 8(3):e175-e183. O'Connell D, Shaverdian N, Kishan AU, Thomas DH, Dou TH, Lewis JH, Lamb JM, Cao M, Tenn S, Percy LP, Low DA. PMID: 29429921.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    225. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning. J Nucl Med. 2018 02; 59(2):230-237. Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG. PMID: 29123013; PMCID: PMC5807533.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    226. Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study. JCO Clin Cancer Inform. 2017 11; 1:1-6. Kishan AU, Cheng EM, Schmidt E, Saigal C, Reiter RE, Kupelian PA, Steinberg ML, King CR. PMID: 30657383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. Online Adaptive Radiation Therapy: Implementation of a New Process of Care. Cureus. 2017 Aug 27; 9(8):e1618. Lamb J, Cao M, Kishan A, Agazaryan N, Thomas DH, Shaverdian N, Yang Y, Ray S, Low DA, Raldow A, Steinberg ML, Lee P. PMID: 29104835; PMCID: PMC5663325.
      View in: PubMed   Mentions: 54  
    228. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy. Brachytherapy. 2017 Nov - Dec; 16(6):1106-1112. Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M. PMID: 28807747.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    229. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease. Br J Radiol. 2017 Aug; 90(1076):20170134. Kishan AU, Voog JC, Wiseman J, Cook RR, Ancukiewicz M, Lee P, Ryan DP, Clark JW, Berger DL, Cusack JC, Wo JY, Hong TS. PMID: 28613934; PMCID: PMC5603953.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    230. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer. Urology. 2017 Sep; 107:171-177. Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. PMID: 28552819; PMCID: PMC6986738.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    231. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study. Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):1045-1052. Wang C, Kishan AU, Kamrava M, Steinberg ML, King CR. PMID: 28721887.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    232. Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer. Semin Radiat Oncol. 2017 07; 27(3):268-278. Kishan AU, King CR. PMID: 28577834.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    233. Treatment trends for patients with brain metastases: Does practice reflect the data? Cancer. 2017 Jun 15; 123(12):2274-2282. Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, Steinberg ML, Lee P. PMID: 28178376.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    234. Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73. Eur Urol. 2017 11; 72(5):e123-e124. Kishan AU, Steinberg ML, Kupelian PA, King CR. PMID: 28111115.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    235. Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf? Cancer. 2017 02 01; 123(3):531-532. Kishan AU, Kupelian PA, Steinberg ML, King CR. PMID: 27997685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    236. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):516-525. Shaverdian N, Verruttipong D, Wang PC, Kishan AU, Demanes DJ, McCloskey S, Kupelian P, Steinberg ML, King CR. PMID: 28126301.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    237. Radiation Therapy for Stage I Nonoperable or Medically Inoperable Lung Cancer. Semin Respir Crit Care Med. 2016 10; 37(5):716-726. Kishan AU, Lee P. PMID: 27732993.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    238. Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI-tri-60Co teletherapy device. Br J Radiol. 2016 Nov; 89(1067):20160624. Raghavan G, Kishan AU, Cao M, Chen AM. PMID: 27653787; PMCID: PMC5124853.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    239. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic. Ann Surg Oncol. 2016 12; 23(Suppl 5):634-641. Kishan AU, Gomez CL, Dawson NA, Dvorak R, Foster NM, Hoyt A, Hurvitz SA, Kusske A, Silver EL, Tseng C, McCloskey SA. PMID: 27619940.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    240. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 05; 71(5):766-773. Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 27452951; PMCID: PMC10262972.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    241. Having Your Cake and Eating It Too: Combining SBRT and Multi-agent Chemotherapy in Locally Advanced Pancreatic Cancer. Cureus. 2016 Jul 13; 8(7):e686. Kishan A, Lee P. PMID: 27555984; PMCID: PMC4981412.
      View in: PubMed   Mentions: 1  
    242. Clinical Indicators of Psychosocial Distress Predict for Acute Radiation-Induced Fatigue in Patients Receiving Adjuvant Radiation Therapy for Breast Cancer: An Analysis of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 01; 95(3):946-955. Kishan AU, Wang PC, Sharif J, Kupelian PA, Steinberg ML, McCloskey SA. PMID: 27105720.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    243. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer. Med Dosim. 2016; 41(1):87-91. Merna C, Rwigema JC, Cao M, Wang PC, Kishan AU, Michailian A, Lamb J, Sheng K, Agazaryan N, Low DA, Kupelian P, Steinberg ML, Lee P. PMID: 26755076.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    244. Lipids and Diabetic Retinopathy. Semin Ophthalmol. 2016; 31(1-2):10-8. Modjtahedi BS, Bose N, Papakostas TD, Morse L, Vavvas DG, Kishan AU. PMID: 26959124.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    245. Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available data. Ther Adv Med Oncol. 2016 Jan; 8(1):85-97. Kishan AU, McCloskey SA. PMID: 26753007; PMCID: PMC4699266.
      View in: PubMed   Mentions: 3  
    246. In Regard to Bauman et al. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1162-3. Kishan AU, Steinberg ML, Kupelian PA, King CR. PMID: 26581152.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    247. SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):268-275. Kishan AU, Wang PC, Upadhyaya SK, Hauswald H, Demanes DJ, Nickols NG, Kamrava M, Sadeghi A, Kupelian PA, Steinberg ML, Prionas ND, Buyyounouski MK, King CR. PMID: 26850649.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    248. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy. Br J Radiol. 2015; 88(1056):20150658. Kishan AU, Park SJ, King CR, Roberts K, Kupelian PA, Steinberg ML, Kamrava M. PMID: 26463234; PMCID: PMC4984947.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    249. Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases. J Contemp Brachytherapy. 2015 Oct; 7(5):327-35. Kishan AU, Lee EW, McWilliams J, Lu D, Genshaft S, Motamedi K, Demanes DJ, Park SJ, Hagio MA, Wang PC, Kamrava M. PMID: 26622237; PMCID: PMC4663208.
      View in: PubMed   Mentions: 6  
    250. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):366-73. Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P. PMID: 26432677.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    251. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):411-6. Kamrava M, Kishan AU, Margolis DJ, Huang J, Dorey F, Lieu P, Kupelian PA, Marks LS. PMID: 26059510; PMCID: PMC4639400.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    252. Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: A comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):330-337. Kishan AU, Cao M, Wang PC, Mikaeilian AG, Tenn S, Rwigema JM, Sheng K, Low DA, Kupelian PA, Steinberg ML, Lee P. PMID: 25823383.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    253. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Mar 15; 91(4):832-9. Kishan AU, Lamb JM, Jani SS, Kang JJ, Steinberg ML, King CR. PMID: 25752398.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    254. Dosimetric feasibility of magnetic resonance imaging-guided tri-cobalt 60 preoperative intensity modulated radiation therapy for soft tissue sarcomas of the extremity. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):350-356. Kishan AU, Cao M, Mikaeilian AG, Low DA, Kupelian PA, Steinberg ML, Kamrava M. PMID: 25749215.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    255. A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):173-8. Mesko S, Park SJ, Kishan AU, Demanes DJ, Kamrava M. PMID: 25537448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    256. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects. Brachytherapy. 2015 Mar-Apr; 14(2):148-59. Kishan AU, Kupelian PA. PMID: 25516492.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    257. Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2015 Aug; 14(4):411-8. Kishan AU, Wang PC, Sheng K, Yu V, Ruan D, Cao M, Tenn S, Low DA, Lee P. PMID: 25261069.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    258. Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck. J Med Imaging Radiat Oncol. 2014 Oct; 58(5):618-24. Kishan AU, Cui J, Wang PC, Daly ME, Purdy JA, Chen AM. PMID: 24942938.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    259. Dose impact in radiographic lung injury following lung SBRT: Statistical analysis and geometric interpretation. Med Phys. 2014 Mar; 41(3):031701. Yu V, Kishan AU, Cao M, Low D, Lee P, Ruan D. PMID: 24593705.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    260. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell. 2012 Oct 16; 22(4):547-60. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, Polak K, Tondera D, Gounarides J, Yin H, Zhou F, Green MR, Chen L, Monti S, Marto JA, Shipp MA, Danial NN. PMID: 23079663; PMCID: PMC3479446.
      View in: PubMed   Mentions: 268     Fields:    Translation:HumansCells
    261. Radiation therapy for neovascular age-related macular degeneration. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):583-97. Kishan AU, Modjtahedi BS, Morse LS, Lee P. PMID: 22975610.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    262. Radiotherapy is effective for a primary lung cancer invading the left atrium. BMJ Case Rep. 2012 Jul 19; 2012. Lee P, Kishan AU. PMID: 22814990; PMCID: PMC4544094.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    263. Shoulder pain and isolated brachial plexopathy. BMJ Case Rep. 2012 Jun 28; 2012. Kishan AU, Syed S, Fiorito-Torres F, Thakore-James M. PMID: 22744250; PMCID: PMC4543111.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    264. Eyelash alopecia areata: case series and literature review. Can J Ophthalmol. 2012 Aug; 47(4):333-8. Modjtahedi BS, Kishan AU, Schwab IR, Jackson WB, Maibach HI. PMID: 22883840.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    265. Patterns of olivocochlear axonal branches. Open J Neurosci. 2011 Oct 12; 1. Kishan AU, Lee CC, Winer JA. PMID: 22348198; PMCID: PMC3279734.
      View in: PubMed   Mentions: 3  
    266. Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):172-178. Kishan AU, Chen MH, Loffredo M, Kim D, Beard CJ, Hurwitz MD, Martin NE, Orio PF, Kantoff PW, D'Amico AV, Nguyen PL. PMID: 24674120.
      View in: PubMed   Mentions:    Fields:    
    267. Wiring of divergent networks in the central auditory system. Front Neuroanat. 2011; 5:46. Lee CC, Kishan AU, Winer JA. PMID: 21847372; PMCID: PMC3147171.
      View in: PubMed   Mentions: 8  
    268. Lipids and age-related macular degeneration. Surv Ophthalmol. 2011 May-Jun; 56(3):195-213. Kishan AU, Modjtahedi BS, Martins EN, Modjtahedi SP, Morse LS. PMID: 21439604.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    269. Branched projections in the auditory thalamocortical and corticocortical systems. Neuroscience. 2008 Jun 12; 154(1):283-93. Kishan AU, Lee CC, Winer JA. PMID: 18294776; PMCID: PMC2629493.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    270. Tension pneumocephalus following posterior fossa surgery in sitting position. A report of 2 cases. Clin Neurol Neurosurg. 1990; 92(3):245-8. Kishan A, Naidu MR, Muralidhar K. PMID: 2171832.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Amar's Networks
    Concepts (399)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (111)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California